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Noonan syndrome (NS) and NS-related disorders
(Cardio-Facio-Cutaneous (CFC) syndrome, Costello
syndrome, LEOPARD (Lentigines, ECG conduction
abnormalities, Ocular hypertelorism, Pulmonic stenosis,
Abnormal genitalia, Retardation of growth and sensory
neural Deafness) syndrome) share common clinical fea-
tures characterized by unique facial features, postnatal
growth failure, psychomotor retardation, ectodermal
abnormalities, congenital heart diseases, chest & skeletal
deformity and delayed puberty. During last decade,
strident progress has been made in molecular under-
standing of NS. The functional alterations of the
Ras-mitogen-activated protein kinase (MAPK) pathway
are caused by the mutation in more than 10 genes
(PTPN11, SOS1, RAF1, SHOC2, BRAF, KRAS, NRAS,
HRAS, MEK1, MEK2). Thus, NS and NS-related disor-
ders are called RASopathies as a disease group. PTPN11
(40-50%), SOS1 (10%–20%), and RAF1 (3%-17%) muta-
tions are common in NS patients. Noonan syndrome
and its related disorders are not rare as a whole. Since
their disease natural course and management are differ-
ent, it is important to recognize RASopathies and differ-
entiate them primarily based on typical clinical feature.
By utilizing DNA testing, the confirmatory diagnosis can
be made. Multi-systemic involvement in RASopathies
requires multidisciplinary evaluation and regular moni-
toring for each special clinical issue. It involves whole
spectra of clinical issues of cardiovascular, growth &
endocrine, neuro-cognitive, developmental, skeletal &
orthopedic, opthalmo-otolaryngological, GI-nutritional,
dental, hemato-oncological and ectodermal systems. For
instances, surgical intervention is required for congenital
heart defects and cryptoorchidism. Before the surgery,
bleeding diathesis should be excluded. Also the risk for
malignant hyperthermia has to be considered in choos-
ing anesthetics. Special education might be required in
10-40% of NS patients. However, NS patients carrying
the mutation in the SOS1 gene and N380D or N380S
mutation in the PTPN11 gene tend to show normal cog-
nitive function. Many NS infants have feeding difficulties
with poor suck and prolonged feeding time and may
require tube feeding in 24% of NS infants. Most NS
patients show normal levels of IGF-1 and IGF-BP3, indi-
cating growth hormone (GH) deficiency is not culpable
for postnatal growth failure. However, some studies
have demonstrated subnormal overnight mean growth
hormone concentration, suggestive of impaired GH
secretion. The rhGH therapy in NS has been reported
to be effective to improve both the height velocity and
the final adult height. In this review, the constellation of
overlapping clinical features of RASopathies will be
described based on genotype as well as their differential
diagnostic points and management.
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